RxSight, Inc. (RXST)
4.85
+0.05
(+1.04%)
USD |
NASDAQ |
Oct 08, 16:00
4.85
0.00 (0.00%)
After-Hours: 20:00
RxSight Enterprise Value : 1.391M for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 1.391M |
| October 06, 2026 | -4.847M |
| October 05, 2026 | -0.2725M |
| October 02, 2026 | -3.599M |
| October 01, 2026 | -0.6883M |
| September 30, 2026 | 5.550M |
| September 29, 2026 | 0.1434M |
| September 28, 2026 | -4.015M |
| September 25, 2026 | -4.431M |
| September 24, 2026 | -1.520M |
| September 23, 2026 | 3.470M |
| September 22, 2026 | 6.797M |
| September 21, 2026 | 15.53M |
| September 18, 2026 | 18.03M |
| September 17, 2026 | 23.02M |
| September 16, 2026 | 26.34M |
| September 15, 2026 | 35.49M |
| September 14, 2026 | 55.66M |
| September 11, 2026 | 52.13M |
| September 10, 2026 | 49.63M |
| September 09, 2026 | 65.02M |
| September 08, 2026 | 70.01M |
| September 04, 2026 | 66.89M |
| September 03, 2026 | 73.75M |
| September 02, 2026 | 94.13M |
| Date | Value |
|---|---|
| September 01, 2026 | 92.46M |
| August 31, 2026 | 106.60M |
| August 28, 2026 | 94.96M |
| August 27, 2026 | 76.66M |
| August 26, 2026 | 67.10M |
| August 25, 2026 | 67.93M |
| August 24, 2026 | 62.11M |
| August 21, 2026 | 61.69M |
| August 20, 2026 | 55.04M |
| August 19, 2026 | 57.95M |
| August 18, 2026 | 66.68M |
| August 17, 2026 | 71.25M |
| August 14, 2026 | 88.30M |
| August 13, 2026 | 93.29M |
| August 12, 2026 | 95.37M |
| August 11, 2026 | 94.54M |
| August 10, 2026 | 75.00M |
| August 07, 2026 | 62.11M |
| August 06, 2026 | 54.62M |
| August 05, 2026 | 63.35M |
| August 04, 2026 | 61.69M |
| August 03, 2026 | 63.35M |
| July 31, 2026 | 51.71M |
| July 30, 2026 | 54.62M |
| July 29, 2026 | 56.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 40.86B |
| Neogen Corp. | 3.150B |
| QuidelOrtho Corp. | 3.793B |
| Aspira Women's Health, Inc. | 14.75M |
| Biomerica, Inc. | 7.178M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.10M |
| Revenue (Quarterly) | 33.74M |
| Total Expenses (Quarterly) | 45.84M |
| EPS Diluted (Quarterly) | -0.2916 |
| Gross Profit Margin (Quarterly) | 76.72% |
| Profit Margin (Quarterly) | -35.85% |
| Earnings Yield | -23.46% |
| Normalized Earnings Yield | -23.46 |